Exercising of Shareholder Rights – Information December 2020 As a result of the adoption of the “Popular Initiative against Fat-Cat Salaries” in 2014, pension funds have an obligation to exercise shareholder rights in the interests of the insured persons and to disclose how the pension funds voted. This regulation applies for public limited companies with registered office in Switzerland and whose shares are listed on a domestic or foreign stock exchange. The Foundation Board of the PensFlex Collective Foundation has incorporated the corresponding regulations into the Art. 3.5 of the Organisational Rules or Art. 4 of the Rules on Investment. A list of the voting record of the PensFlex Collective Foundation in the year 2020 is shown below. Voting Report for PensFlex Sammelstiftung Kauffmannweg 16 6003 Luzern This report summarizes voting behaviour according to the following specifications: Time period: 01.01.2020 - 31.12.2020 Agenda items: Summary of all items on the agenda, i.e. not only the items requiring a vote according to Art. 22 para. 1 ORAb. The voting rights were exercised for the following companies: Perrot Duval 06.02.2020 Kardex 14.04.2020 Novartis 28.02.2020 Tornos 15.04.2020 Dätwyler 11.03.2020 Georg Fischer 15.04.2020 Roche 17.03.2020 Sulzer 15.04.2020 BB Biotech 19.03.2020 Evolva 15.04.2020 Schindler 19.03.2020 Mikron 15.04.2020 Swiss Prime Site 24.03.2020 Ascom 15.04.2020 Implenia 24.03.2020 Kudelski 15.04.2020 Bellevue 24.03.2020 Adecco 16.04.2020 SGS 24.03.2020 Rieter 16.04.2020 ALSO 24.03.2020 Cembra Money Bank 16.04.2020 Givaudan 25.03.2020 Swiss Re 17.04.2020 Autoneum 25.03.2020 Siegfried 17.04.2020 ABB 26.03.2020 Calida 17.04.2020 Belimo 30.03.2020 Sika 21.04.2020 Mobimo 31.03.2020 Bachem 22.04.2020 Leonteq 31.03.2020 Vetropack 22.04.2020 SenioResidenz 01.04.2020 Santhera Pharmaceuticals 22.04.2020 Geberit 01.04.2020 Conzzeta 22.04.2020 Zurich Insurance Group 01.04.2020 SFS 23.04.2020 Huber+Suhner 01.04.2020 u-blox 23.04.2020 Coltene 02.04.2020 Nestlé 23.04.2020 Emmi 02.04.2020 Zur Rose 23.04.2020 Inficon 03.04.2020 Comet 23.04.2020 TX Group 03.04.2020 Bucher 24.04.2020 Forbo 03.04.2020 Bâloise 24.04.2020 Swisscom 06.04.2020 Allreal 24.04.2020 OC Oerlikon 07.04.2020 Metall Zug 24.04.2020 SIG Combibloc 07.04.2020 Helvetia 24.04.2020 Bobst 07.04.2020 Edisun 24.04.2020 Straumann 07.04.2020 Lindt & Sprüngli 24.04.2020 Zug Estates 07.04.2020 Arbonia 24.04.2020 VZ Holding 08.04.2020 Swiss Life 28.04.2020 Fundamenta Real Estate 08.04.2020 Lonza Group 28.04.2020 Bossard 08.04.2020 Investis 28.04.2020 mobilezone 08.04.2020 Molecular Partners 29.04.2020 Schweiter Technologies 08.04.2020 UBS 29.04.2020 Basilea 08.04.2020 EFG International 29.04.2020 Sunrise Communications 08.04.2020 Feintool 30.04.2020 Luzerner Kantonalbank 08.04.2020 Stadler Rail 30.04.2020 PSP Swiss Property 09.04.2020 Credit Suisse 30.04.2020 Plazza 09.04.2020 Banque Cantonale Vaudoise 30.04.2020 GAM 30.04.2020 HBM Healthcare Investments 22.06.2020 Zuger Kantonalbank 02.05.2020 Burkhalter 24.06.2020 Kühne + Nagel 05.05.2020 SenioResidenz 26.06.2020 Swissquote 05.05.2020 Clariant 29.06.2020 Pargesa 06.05.2020 Private Equity Holding 30.06.2020 Alcon 06.05.2020 Ypsomed 01.07.2020 Cham Group 06.05.2020 Burckhardt Compression 03.07.2020 Transocean 07.05.2020 Dottikon ES 03.07.2020 Komax 11.05.2020 Meyer Burger 10.07.2020 Sensirion 11.05.2020 EMS-Chemie 08.08.2020 Vaudoise Assurances 11.05.2020 Kühne + Nagel 02.09.2020 Bell 12.05.2020 Pargesa 04.09.2020 Berner Kantonalbank 12.05.2020 Logitech 09.09.2020 LafargeHolcim 12.05.2020 Richemont 09.09.2020 DKSH 13.05.2020 Aryzta 16.09.2020 Hypothekarbank Lenzburg 13.05.2020 Dufry 06.10.2020 Idorsia 13.05.2020 Peach Property Group 12.10.2020 nebag 13.05.2020 dormakaba 20.10.2020 Meyer Burger 13.05.2020 Züblin Immobilien 21.10.2020 Partners Group 13.05.2020 Sunrise Communications 09.11.2020 Swatch Group 14.05.2020 Richemont 17.11.2020 APG 14.05.2020 UBS 19.11.2020 SoftwareONE 14.05.2020 Dottikon ES 27.11.2020 VAT Group 14.05.2020 Credit Suisse 27.11.2020 Vifor Pharma 14.05.2020 EFG International 08.12.2020 BKW 15.05.2020 Barry Callebaut 09.12.2020 Jungfraubahn 18.05.2020 Aryzta 15.12.2020 Dufry 18.05.2020 Relief Therapeutics 17.12.2020 Tradition 19.05.2020 Galenica 19.05.2020 Valartis Group 19.05.2020 Romande Energie 19.05.2020 Orascom 20.05.2020 Temenos 20.05.2020 Alpine Select 20.05.2020 Spice Private Equity 27.05.2020 Peach Property Group 27.05.2020 Orior 04.06.2020 Valora 11.06.2020 Flughafen Zürich 11.06.2020 Sonova 11.06.2020 Züblin Immobilien 17.06.2020 Detailed overview Summary Approval of the management report and the annual and consolidated financial statements 2842 Agenda items 147 Agenda items thereof approval: 2294 thereof approval: 146 thereof rejection: 547 thereof rejection: 1 thereof abstention: 1 thereof abstention: 0 Dividend payment Payout from capital reserves 130 Agenda items 37 Agenda items thereof approval: 130 thereof approval: 37 thereof rejection: 0 thereof rejection: 0 thereof abstention: 0 thereof abstention: 0 Par value reduction Discharge BoD/BoM 9 Agenda items 111 Agenda items thereof approval: 8 thereof approval: 109 thereof rejection: 1 thereof rejection: 2 thereof abstention: 0 thereof abstention: 0 Discharge BoD Discharge BoM 34 Agenda items 5 Agenda items thereof approval: 34 thereof approval: 5 thereof rejection: 0 thereof rejection: 0 thereof abstention: 0 thereof abstention: 0 Consultative vote on compensation report Compensation vote BoD: fixed, prospective 97 Agenda items 131 Agenda items thereof approval: 48 thereof approval: 112 thereof rejection: 49 thereof rejection: 19 thereof abstention: 0 thereof abstention: 0 Compensation vote BoD: fixed, retrospective Compensation vote BoD: variable, prospective 7 Agenda items 6 Agenda items thereof approval: 5 thereof approval: 2 thereof rejection: 2 thereof rejection: 4 thereof abstention: 0 thereof abstention: 0 Compensation vote BoD: variable, retrospective Compensation vote BoM: fixed, prospective 7 Agenda items 56 Agenda items thereof approval: 0 thereof approval: 50 thereof rejection: 7 thereof rejection: 6 thereof abstention: 0 thereof abstention: 0 Compensation vote BoM: fixed, retrospective Compensation vote BoM: Variable, prospective 4 Agenda items 96 Agenda items thereof approval: 3 thereof approval: 63 thereof rejection: 1 thereof rejection: 33 thereof abstention: 0 thereof abstention: 0 Compensation vote BoM: Variable, Retrospective Re-election Chairman 47 Agenda items 118 Agenda items thereof approval: 32 thereof approval: 96 thereof rejection: 15 thereof rejection: 22 thereof abstention: 0 thereof abstention: 0 Election Chairman Election of new Board of Directors 17 Agenda items 131 Agenda items thereof approval: 17 thereof approval: 123 thereof rejection: 0 thereof rejection: 7 thereof abstention: 0 thereof abstention: 1 Re-election BoD Re-election Compensation Committee 819 Agenda items 346 Agenda items thereof approval: 699 thereof approval: 187 thereof rejection: 120 thereof rejection: 159 thereof abstention: 0 thereof abstention: 0 Election Compensation Committee Election Independent Proxy 75 Agenda items 138 Agenda items thereof approval: 67 thereof approval: 109 thereof rejection: 8 thereof rejection: 29 thereof abstention: 0 thereof abstention: 0 Election of auditor Ordinary capital increase 139 Agenda items 3 Agenda items thereof approval: 113 thereof approval: 3 thereof rejection: 26 thereof rejection: 0 thereof abstention: 0 thereof abstention: 0 Conditional capital: Extension Conditional capital: Creation 4 Agenda items 9 Agenda items thereof approval: 4 thereof approval: 3 thereof rejection: 0 thereof rejection: 6 thereof abstention: 0 thereof abstention: 0 Authorized capital: Extension Authorized capital: Creation 23 Agenda items 17 Agenda items thereof approval: 15 thereof approval: 9 thereof rejection: 8 thereof rejection: 8 thereof abstention: 0 thereof abstention: 0 Capital reduction Share buyback programme 15 Agenda items 2 Agenda items thereof approval: 12 thereof approval: 1 thereof rejection: 3 thereof rejection: 1 thereof abstention: 0 thereof abstention: 0 Amendments to the Articles of Incorporation Corporate Editorial revision of the Articles of Incorporation Governance 25 Agenda items 1 Agenda items thereof approval: 20 thereof approval: 1 thereof rejection: 5 thereof rejection: 0 thereof abstention: 0 thereof abstention: 0 Other amendments to the Articles of Incorporation M&A/restructuring 9 Agenda items 1 Agenda items thereof approval: 9 thereof approval: 1 thereof rejection: 0 thereof rejection: 0 thereof abstention: 0 thereof abstention: 0 Other topics Shareholder proposals: Election of the Board of Directors 6 Agenda items 6 Agenda items thereof approval: 5 thereof approval: 4 thereof rejection: 1 thereof rejection: 2 thereof abstention: 0 thereof abstention: 0 Amendments to the Articles of Incorporation ORAb 9 Agenda items 2 Agenda items thereof approval: 8 thereof approval: 1 thereof rejection: 1 thereof rejection: 1 thereof abstention: 0 thereof abstention: 0 No vote Compensation voting Advisory Board 7 Agenda items 3 Agenda items thereof approval: 4 thereof approval: 3 thereof rejection: 3 thereof rejection: 0 thereof abstention: 0 thereof abstention: 0.